Company page
Uwell Biopharma Inc.
Uwell Biopharma Inc. is a public company listed on the Taiwan market under the ticker 7902. The company has a market capitalization of approximately NT$253.92 million. Uwell Biopharma focuses on biopharmaceutical development and innovation in the healthcare sector.
- Ticker
- 7902
- Market cap
- $253.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major